Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
International Journal of Cardiology|September 3, 2018
Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV surveyDelphine De Smedt, Lieven Annemans, Guy De Backer, et al.The Lancet. Diabetes & Endocrinology|March 31, 2015
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveysKaveh Hajifathalian, Peter Ueda, Yuan Lu, et al.European Journal of Preventive Cardiology|May 9, 2021
Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countriesKornelia Kotseva, Guy De Backer, Dirk De Bacquer, et al.The New England Journal of Medicine|August 29, 2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseasePaul M Ridker, Brendan M Everett, Tom Thuren, et al.Cardiovascular Diabetology|October 3, 2015
Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of CardiologyViveca Gyberg, Dirk De Bacquer, Guy De Backer, et al.The Lancet. Diabetes & Endocrinology|January 28, 2017
Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveysPeter Ueda, Mark Woodward, Yuan Lu, et al.European Journal of Preventive Cardiology|February 12, 2019
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registryKornelia Kotseva, Guy De Backer, Dirk De Bacquer, et al.Journal of Hypertension|July 1, 2014
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidenceAlberto Zanchetti, Lisheng Liu, Giuseppe Mancia, et al.Journal of Hypertension|July 1, 2014
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trialAlberto Zanchetti, Lisheng Liu, Giuseppe Mancia, et al.Journal of Hypertension|June 22, 2023
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.Pageof 5